Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
23
天
Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth
作者
Kanako Yokomizo; Kayoko Waki; Miyako Ozawa; Keiko Yamamoto; Sachiko Ogasawara; Hirohisa Yano; Akira Yamada展开收起
作者单位
1. Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan; 2. Department of Pathology, Kurume University School of Medicine, Kurume, Japan展开收起
26
天
Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions
作者
Maryana Teufelsbauer; Clemens Lang; Adelina Plangger; Barbara Rath; Doris Moser; Clement Staud; Christine Radtke; Christoph Neumayer; Gerhard Hamilton展开收起
作者单位
1. Department of Plastic and Reconstructive Surgery, Medical University of Vienna, Vienna, Austria; 2. Department of Trauma Surgery, Sozialmedizinisches Zentrum Ost, Donauspital, Vienna, Austria; 3. Institute of Pharmacology, Medical University of Vienna, Vienna, Austria; 4. Department of Cranio, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria; 5. Department of Vascular Surgery, Medical University of Vienna, Vienna, Austria展开收起
54
天
ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma
作者
Guoxin Hou; Zhimin Lu; Yanyu Bi; Jingjing Deng; Xinmei Yang展开收起
作者单位
1. Department of Oncology, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China; 2. Department of Outpatient, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China; 3. Department of Respiratory, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China展开收起
73
天
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
作者
Hua Zhang; Jintong Chen; Mingyue Zhang; Munan Zhao; Luyao Zhang; Bin Liu; Siqing Wang展开收起
作者单位
1. Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China; 2. Department of Cancer Immunology, The First Hospital of Jilin University, Changchun, China; 3. Department of Gynecological Oncology, The First Hospital of Jilin University, Changchun, China; 4. Department of Cancer Center, The First Hospital of Jilin University, Changchun, China; 5. Department of Hand and Foot Surgery, The First Hospital of Jilin University, Changchun, China展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
